The comparison data between all three agents, semaglutide vs tirzepatide vs retatrutide , provides a framework for understanding dose-response relationships and receptor pharmacology that extends beyond any single compound
Retatrutide, which has not yet completed clinical trials, is an experimental injection developed by the US drugmaker Eli Lilly that targets three gut hormones: GLP-1, GIP and glucagon
Medication shown not representative of actual product, which is dispensed by a local pharmacy
The meatballs add a boost of protein, helping you feel full and supporting your metabolism
The drugs are among several pharmacological options that providers have to treat endocrine diseases
Most insurance plans cover GLP-1 medications only when prescribed for diabetes or, in some cases, obesity with specific BMI criteria